Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism.

PubWeight™: 1.86‹?› | Rank: Top 3%

🔗 View Article (PMID 16618418)

Published in Gastroenterology on April 01, 2006

Authors

Eugenio Gaudio1, Barbara Barbaro, Domenico Alvaro, Shannon Glaser, Heather Francis, Yoshiyuki Ueno, Cynthia J Meininger, Antonio Franchitto, Paolo Onori, Marco Marzioni, Silvia Taffetani, Giammarco Fava, George Stoica, Julie Venter, Ramona Reichenbach, Sharon De Morrow, Ryun Summers, Gianfranco Alpini

Author Affiliations

1: Division of Anatomy, University "La Sapienza," Rome, Italy.

Articles citing this

Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res (2014) 2.51

Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol (2008) 2.26

Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol (2008) 1.57

Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med (2009) 1.32

ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice. Gastroenterology (2009) 1.29

Polycystic liver diseases: congenital disorders of cholangiocyte signaling. Gastroenterology (2011) 1.26

H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest (2007) 1.24

Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol (2006) 1.20

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol (2008) 1.18

Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig Liver Dis (2008) 1.18

Epithelial-mesenchymal interactions in biliary diseases. Semin Liver Dis (2011) 1.11

Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut (2011) 1.08

Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol (2009) 1.08

Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol (2006) 1.07

H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. Mol Cancer Res (2009) 1.06

Molecular pathogenesis of cholangiocarcinoma. Int J Hepatol (2011) 1.02

The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech (2013) 1.01

Cholangiocytes and blood supply. World J Gastroenterol (2006) 1.00

Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. Am J Physiol Gastrointest Liver Physiol (2008) 1.00

Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib. Hepatology (2012) 0.99

Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model. Int J Hepatol (2011) 0.96

Recent advances in the regulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol (2010) 0.95

Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. Gastroenterology (2014) 0.95

Polycystic liver diseases. Dig Liver Dis (2010) 0.93

Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of Ca2+-dependent PKC isoforms. BMC Physiol (2007) 0.93

Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. Exp Biol Med (Maywood) (2009) 0.92

Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment. Transl Gastrointest Cancer (2012) 0.91

Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat. Am J Physiol Gastrointest Liver Physiol (2011) 0.91

Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) (2013) 0.89

Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes in rats. Hepatology (2013) 0.88

Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis (2010) 0.88

Vascular factors, angiogenesis and biliary tract disease. Curr Opin Gastroenterol (2010) 0.88

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression. Liver Int (2009) 0.87

Effects of warm ischemia time on biliary injury in rat liver transplantation. World J Gastroenterol (2012) 0.87

Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol (2011) 0.87

Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms. Lab Invest (2011) 0.86

Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats. Braz J Med Biol Res (2014) 0.85

Control of cholangiocyte adaptive responses by visceral hormones and neuropeptides. Clin Rev Allergy Immunol (2009) 0.85

Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology. Ann Transl Med (2013) 0.84

The crucial role of cholangiocytes in cholangiopathies. Gut Liver (2012) 0.84

Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis (2014) 0.83

Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases. Am J Pathol (2011) 0.82

Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents. Lab Invest (2014) 0.82

Biliary infection may exacerbate biliary cystogenesis through the induction of VEGF in cholangiocytes of the polycystic kidney (PCK) rat. Am J Pathol (2011) 0.82

The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1. Am J Physiol Gastrointest Liver Physiol (2012) 0.81

Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats. Dig Liver Dis (2010) 0.80

Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease. Liver Int (2013) 0.80

Functional and structural features of cholangiocytes in health and disease. Cell Mol Gastroenterol Hepatol (2015) 0.79

Autocrine regulation of biliary pathology by activated cholangiocytes. Am J Physiol Gastrointest Liver Physiol (2011) 0.79

Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib. Clin Pract (2014) 0.79

Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol (2014) 0.78

Development of an experimental model of cholestasis induced by hypoxic/ischemic damage to the bile duct and liver tissues in infantile rats. J Gastroenterol (2011) 0.78

Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage. Hepatology (2015) 0.78

Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis. Cell Mol Gastroenterol Hepatol (2015) 0.77

Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation. Dig Liver Dis (2008) 0.77

Regulators of Cholangiocyte Proliferation. Gene Expr (2016) 0.77

Mechanisms of Biliary Damage. J Cell Death (2010) 0.77

The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 0.77

Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone. Am J Physiol Gastrointest Liver Physiol (2011) 0.77

Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms. Am J Physiol Gastrointest Liver Physiol (2013) 0.77

Development and functional characterization of extrahepatic cholangiocyte lines from normal rats. Dig Liver Dis (2015) 0.76

Nonselective inhibition of prostaglandin-endoperoxide synthases by naproxen ameliorates acute or chronic liver injury in animals. Exp Mol Pathol (2013) 0.76

Beyond scar formation: portal myofibroblast-mediated angiogenesis in the fibrotic liver. Hepatology (2015) 0.76

Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit(W-sh) mice. Hepatology (2017) 0.75

The Neuropeptide Galanin Is Up-Regulated during Cholestasis and Contributes to Cholangiocyte Proliferation. Am J Pathol (2017) 0.75

Inhibition of the liver expression of arylalkylamine N-acetyltransferase increases the expression of angiogenic factors in cholangiocytes. Hepatobiliary Surg Nutr (2014) 0.75

Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction in growing animals: immunohistochemical analysis of the expression of TGF-β and VEGF. Clinics (Sao Paulo) (2012) 0.75

Mechanisms of Biliary Damage. J Cell Death (2010) 0.75

miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation. Am J Pathol (2017) 0.75

Detection of Autoantibodies to Vascular Endothelial Growth Factor Receptor-3 in Bile Duct Ligated Rats and Correlations with a Panel of Traditional Markers of Liver Diseases. Dis Markers (2016) 0.75

Role of sex hormones in the modulation of cholangiocyte function. World J Gastrointest Pathophysiol (2010) 0.75

Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors. Am J Physiol Gastrointest Liver Physiol (2015) 0.75

The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol (2016) 0.75

Biology of Cholangiocytes: From Bench to Bedside. Gut Liver (2016) 0.75

Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms. Am J Pathol (2015) 0.75

Isolation and characterization of hepatic mast cells from cholestatic rats. Lab Invest (2016) 0.75

Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b. Am J Pathol (2017) 0.75

Articles by these authors

Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat Biotechnol (2006) 14.96

Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain. Nat Biotechnol (2003) 11.28

Noninvasive imaging of hemoglobin concentration and oxygenation in the rat brain using high-resolution photoacoustic tomography. J Biomed Opt (2006) 3.52

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15

Three-dimensional imaging of skin melanoma in vivo by dual-wavelength photoacoustic microscopy. J Biomed Opt (2006) 3.08

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology (2011) 3.00

Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest (2008) 2.89

Photoacoustic imaging of lacZ gene expression in vivo. J Biomed Opt (2007) 2.76

Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology (2011) 2.37

Maternal nutrition and fetal development. J Nutr (2004) 2.31

Imaging of tumor angiogenesis in rat brains in vivo by photoacoustic tomography. Appl Opt (2005) 2.31

Photoacoustic imaging of the microvasculature with a high-frequency ultrasound array transducer. J Biomed Opt (2007) 2.26

Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles. J Physiol (2004) 2.18

Human hepatic stem cell and maturational liver lineage biology. Hepatology (2011) 1.99

Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology (2006) 1.98

Noninvasive photoacoustic angiography of animal brains in vivo with near-infrared light and an optical contrast agent. Opt Lett (2004) 1.97

Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94

IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91

The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem (2007) 1.90

Improved in vivo photoacoustic microscopy based on a virtual-detector concept. Opt Lett (2006) 1.89

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. Hepatology (2014) 1.86

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83

Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology (2012) 1.81

Limitations of quantitative photoacoustic measurements of blood oxygenation in small vessels. Phys Med Biol (2007) 1.79

Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem (2006) 1.77

Optical-fiber-based Mueller optical coherence tomography. Opt Lett (2003) 1.75

In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. Int J Oncol (2007) 1.72

Multiple-bandwidth photoacoustic tomography. Phys Med Biol (2004) 1.70

A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol (2006) 1.70

Imaging acute thermal burns by photoacoustic microscopy. J Biomed Opt (2006) 1.69

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes. J Hepatol (2005) 1.69

The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Hepatology (2011) 1.67

Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology (2009) 1.65

Three-dimensional laser-induced photoacoustic tomography of mouse brain with the skin and skull intact. Opt Lett (2003) 1.63

Cholangiocarcinoma: update and future perspectives. Dig Liver Dis (2010) 1.58

Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol (2006) 1.57

Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol (2008) 1.57

Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat (2011) 1.51

The biliary tree--a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol (2012) 1.50

Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology (2010) 1.48

The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol (2006) 1.47

cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol (2004) 1.46

Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest (2009) 1.45

Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology (2006) 1.44

Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr (2005) 1.44

Association of Treatment for Hyperlipidemia with Decreased Total Mortality in Japanese Individuals: the Yamagata (Takahata) Study. J Atheroscler Thromb (2015) 1.44

Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients. J Gastroenterol (2006) 1.44

Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. J Biol Chem (2007) 1.43

Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int (2003) 1.42

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet (2010) 1.42

Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. J Biol Chem (2003) 1.41

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40

In-vivo photoacoustic microscopy of nanoshell extravasation from solid tumor vasculature. J Biomed Opt (2009) 1.40

Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology (2005) 1.38

Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem (2002) 1.37

Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol (2010) 1.36

Activities of arginase I and II are limiting for endothelial cell proliferation. Am J Physiol Regul Integr Comp Physiol (2002) 1.35